{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,23]],"date-time":"2026-09-23T21:51:36Z","timestamp":1790200296501,"version":"4.1.0"},"reference-count":35,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2017,11,1]],"date-time":"2017-11-01T00:00:00Z","timestamp":1509494400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Toxicology and Applied Pharmacology"],"published-print":{"date-parts":[[2017,11]]},"DOI":"10.1016\/j.taap.2017.08.017","type":"journal-article","created":{"date-parts":[[2017,9,1]],"date-time":"2017-09-01T14:33:27Z","timestamp":1504276407000},"page":"18-23","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":11,"special_numbering":"C","title":["A cell impedance-based real-time in vitro assay to assess the toxicity of amphotericin B formulations"],"prefix":"10.1016","volume":"334","author":[{"given":"Jean","family":"Menotti","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alexandre","family":"Alanio","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Aude","family":"Sturny-Lecl\u00e8re","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sandrine","family":"Vitry","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-8065-4439","authenticated-orcid":false,"given":"F\u00e9lix","family":"Sauvage","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gillian","family":"Barratt","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"St\u00e9phane","family":"Bretagne","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.taap.2017.08.017_bb0005","doi-asserted-by":"crossref","first-page":"712","DOI":"10.1016\/j.chembiol.2009.05.011","article-title":"Kinetic cell-based morphological screening: prediction of mechanism of compound action and off-target effects","volume":"16","author":"Abassi","year":"2009","journal-title":"Chem. Biol."},{"issue":"Suppl. 4","key":"10.1016\/j.taap.2017.08.017_bb0010","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1111\/j.1469-0691.2008.01979.x","article-title":"Amphotericin B lipid preparations: what are the differences?","volume":"14","author":"Adler-Moore","year":"2008","journal-title":"Clin. Microbiol. Infect."},{"key":"10.1016\/j.taap.2017.08.017_bb0015","doi-asserted-by":"crossref","first-page":"67","DOI":"10.1517\/17425255.2014.854329","article-title":"The role of in vitro methods as alternatives to animals in toxicity testing","volume":"10","author":"Anadon","year":"2014","journal-title":"Expert Opin. Drug Metab. Toxicol."},{"key":"10.1016\/j.taap.2017.08.017_bb0020","doi-asserted-by":"crossref","first-page":"174","DOI":"10.1099\/jmm.0.005488-0","article-title":"Aspergillus fumigatus germ tube growth and not conidia ingestion induces expression of inflammatory mediator genes in the human lung epithelial cell line A549","volume":"58","author":"Bellanger","year":"2009","journal-title":"J. Med. Microbiol."},{"key":"10.1016\/j.taap.2017.08.017_bb0025","doi-asserted-by":"crossref","first-page":"348","DOI":"10.1056\/NEJMoa061094","article-title":"Posaconazole vs. fluconazole or itraconazole prophylaxis in patients with neutropenia","volume":"356","author":"Cornely","year":"2007","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.taap.2017.08.017_bb0030","doi-asserted-by":"crossref","first-page":"232","DOI":"10.1097\/01.TP.0000101516.08327.A9","article-title":"Comparative safety of amphotericin B lipid complex and amphotericin B deoxycholate as aerosolized antifungal prophylaxis in lung-transplant recipients","volume":"77","author":"Drew","year":"2004","journal-title":"Transplantation"},{"key":"10.1016\/j.taap.2017.08.017_bb0035","doi-asserted-by":"crossref","first-page":"104","DOI":"10.1111\/myc.12283","article-title":"Comparison of nephrotoxicity associated to different lipid formulations of amphotericin B: a real-life study","volume":"58","author":"Falci","year":"2015","journal-title":"Mycoses"},{"key":"10.1016\/j.taap.2017.08.017_bb0040","doi-asserted-by":"crossref","first-page":"106","DOI":"10.1016\/j.ijpharm.2012.07.012","article-title":"Aerosolized liposomal amphotericin B: prediction of lung deposition, in vitro uptake and cytotoxicity","volume":"436","author":"Fauvel","year":"2012","journal-title":"Int. J. Pharm."},{"key":"10.1016\/j.taap.2017.08.017_bb0045","doi-asserted-by":"crossref","first-page":"3028","DOI":"10.1128\/AAC.49.7.3028-3030.2005","article-title":"Efficacy of nebulized liposomal amphotericin B in treatment of experimental pulmonary aspergillosis","volume":"49","author":"Gavalda","year":"2005","journal-title":"Antimicrob. Agents Chemother."},{"key":"10.1016\/j.taap.2017.08.017_bb0050","doi-asserted-by":"crossref","first-page":"307","DOI":"10.1002\/ppul.20594","article-title":"Novel tobramycin inhalation powder in cystic fibrosis subjects: pharmacokinetics and safety","volume":"42","author":"Geller","year":"2007","journal-title":"Pediatr. Pulmonol."},{"key":"10.1016\/j.taap.2017.08.017_bb0055","doi-asserted-by":"crossref","first-page":"183","DOI":"10.1016\/j.taap.2012.02.010","article-title":"Nitrative DNA damage induced by multi-walled carbon nanotube via endocytosis in human lung epithelial cells","volume":"260","author":"Guo","year":"2012","journal-title":"Toxicol. Appl. Pharmacol."},{"key":"10.1016\/j.taap.2017.08.017_bb0060","doi-asserted-by":"crossref","first-page":"49","DOI":"10.1016\/j.toxicon.2013.10.028","article-title":"Bacillus cereus enterotoxins act as major virulence factors and exhibit distinct cytotoxicity to different human cell lines","volume":"77","author":"Jessberger","year":"2014","journal-title":"Toxicon"},{"key":"10.1016\/j.taap.2017.08.017_bb0065","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1007\/978-1-61779-108-6_6","article-title":"The xCELLigence system for real-time and label-free monitoring of cell viability","volume":"740","author":"Ke","year":"2011","journal-title":"Methods Mol. Biol. (Clifton, NJ)"},{"key":"10.1016\/j.taap.2017.08.017_bb0070","doi-asserted-by":"crossref","first-page":"553","DOI":"10.1128\/AAC.45.2.553-562.2001","article-title":"Reduction of no synthase expression and tumor necrosis factor alpha production in macrophages by amphotericin B lipid carriers","volume":"45","author":"Larabi","year":"2001","journal-title":"Antimicrob. Agents Chemother."},{"key":"10.1016\/j.taap.2017.08.017_bb0075","doi-asserted-by":"crossref","first-page":"3774","DOI":"10.1128\/AAC.47.12.3774-3779.2003","article-title":"Toxicity and antileishmanial activity of a new stable lipid suspension of amphotericin B","volume":"47","author":"Larabi","year":"2003","journal-title":"Antimicrob. Agents Chemother."},{"key":"10.1016\/j.taap.2017.08.017_bb0080","doi-asserted-by":"crossref","first-page":"81","DOI":"10.1093\/jac\/dkh025","article-title":"Study of the toxicity of a new lipid complex formulation of amphotericin B","volume":"53","author":"Larabi","year":"2004","journal-title":"J. Antimicrob. Chemother."},{"key":"10.1016\/j.taap.2017.08.017_bb0085","doi-asserted-by":"crossref","first-page":"311","DOI":"10.3109\/10611869708995847","article-title":"Release of amphotericin B from delivery systems and its action against fungal and mammalian cells","volume":"4","author":"Legrand","year":"1997","journal-title":"J. Drug Target."},{"key":"10.1016\/j.taap.2017.08.017_bb0090","doi-asserted-by":"crossref","first-page":"402","DOI":"10.1006\/meth.2001.1262","article-title":"Analysis of relative gene expression data using real-time quantitative PCR and the 2(-Delta Delta C(T)) Method","volume":"25","author":"Livak","year":"2001","journal-title":"Methods"},{"key":"10.1016\/j.taap.2017.08.017_bb0095","doi-asserted-by":"crossref","first-page":"1882","DOI":"10.1111\/j.1469-0691.2011.03548.x","article-title":"Epidemiological trends in invasive aspergillosis in France: the SAIF network (2005\u20132007)","volume":"17","author":"Lortholary","year":"2011","journal-title":"Clin. Microbiol. Infect."},{"key":"10.1016\/j.taap.2017.08.017_bb0100","doi-asserted-by":"crossref","first-page":"121","DOI":"10.1111\/j.1399-3062.2007.00209.x","article-title":"Safety of aerosolized liposomal versus deoxycholate amphotericin B formulations for prevention of invasive fungal infections following lung transplantation: a retrospective study","volume":"9","author":"Lowry","year":"2007","journal-title":"Transpl. Infect. Dis."},{"key":"10.1016\/j.taap.2017.08.017_bb0105","doi-asserted-by":"crossref","first-page":"313","DOI":"10.1016\/j.healun.2012.11.013","article-title":"Prophylaxis with nebulized liposomal amphotericin B for Aspergillus infection in lung transplant patients does not cause changes in the lipid content of pulmonary surfactant","volume":"32","author":"Monforte","year":"2013","journal-title":"J Heart Lung Transplant"},{"key":"10.1016\/j.taap.2017.08.017_bb0110","doi-asserted-by":"crossref","first-page":"1983","DOI":"10.1378\/chest.123.6.1983","article-title":"The pulmonary effects of long-term exposure to aerosol pentamidine: a 5-year surveillance study in HIV-infected patients","volume":"123","author":"Obaji","year":"2003","journal-title":"Chest"},{"key":"10.1016\/j.taap.2017.08.017_bb0115","doi-asserted-by":"crossref","first-page":"259","DOI":"10.1128\/AAC.00870-07","article-title":"Comparison of the physicochemical, antifungal, and toxic properties of two liposomal amphotericin B products","volume":"52","author":"Olson","year":"2008","journal-title":"Antimicrob. Agents Chemother."},{"key":"10.1016\/j.taap.2017.08.017_bb0120","doi-asserted-by":"crossref","first-page":"545","DOI":"10.1097\/00007890-200108150-00036","article-title":"Safety of aerosolized amphotericin B lipid complex in lung transplant recipients","volume":"72","author":"Palmer","year":"2001","journal-title":"Transplantation"},{"key":"10.1016\/j.taap.2017.08.017_bb0125","doi-asserted-by":"crossref","first-page":"1401","DOI":"10.1086\/586739","article-title":"Aerosolized liposomal amphotericin B for the prevention of invasive pulmonary aspergillosis during prolonged neutropenia: a randomized, placebo-controlled trial","volume":"46","author":"Rijnders","year":"2008","journal-title":"Clin. Infect. Dis."},{"key":"10.1016\/j.taap.2017.08.017_bb0130","doi-asserted-by":"crossref","first-page":"241","DOI":"10.1016\/j.taap.2008.04.010","article-title":"Styrene induces an inflammatory response in human lung epithelial cells via oxidative stress and NF-kappaB activation","volume":"231","author":"Roder-Stolinski","year":"2008","journal-title":"Toxicol. Appl. Pharmacol."},{"key":"10.1016\/j.taap.2017.08.017_bb0135","doi-asserted-by":"crossref","first-page":"89","DOI":"10.1093\/jac\/48.1.89","article-title":"Efficacy of aerosolized amphotericin B desoxycholate and liposomal amphotericin B in the treatment of invasive pulmonary aspergillosis in severely immunocompromised rats","volume":"48","author":"Ruijgrok","year":"2001","journal-title":"J. Antimicrob. Chemother."},{"key":"10.1016\/j.taap.2017.08.017_bb0140","doi-asserted-by":"crossref","first-page":"855","DOI":"10.1016\/j.pupt.2008.09.001","article-title":"Tolerability of prophylactic aerosolized liposomal amphotericin-B and impact on pulmonary function: data from a randomized placebo-controlled trial","volume":"21","author":"Slobbe","year":"2008","journal-title":"Pulm. Pharmacol. Ther."},{"key":"10.1016\/j.taap.2017.08.017_bb0145","doi-asserted-by":"crossref","first-page":"e219","DOI":"10.1371\/journal.pmed.0050219","article-title":"Emergence of azole resistance in Aspergillus fumigatus and spread of a single resistance mechanism","volume":"5","author":"Snelders","year":"2008","journal-title":"PLoS Med."},{"key":"10.1016\/j.taap.2017.08.017_bb0150","doi-asserted-by":"crossref","first-page":"3508","DOI":"10.1128\/AAC.00285-09","article-title":"Efficacy of combination antifungal therapy with intraperitoneally administered micafungin and aerosolized liposomal amphotericin B against murine invasive pulmonary aspergillosis","volume":"53","author":"Takazono","year":"2009","journal-title":"Antimicrob. Agents Chemother."},{"key":"10.1016\/j.taap.2017.08.017_bb0155","doi-asserted-by":"crossref","first-page":"335","DOI":"10.1056\/NEJMoa061098","article-title":"Posaconazole or fluconazole for prophylaxis in severe graft-versus-host disease","volume":"356","author":"Ullmann","year":"2007","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.taap.2017.08.017_bb0160","doi-asserted-by":"crossref","first-page":"30","DOI":"10.1016\/j.drup.2015.08.001","article-title":"International expert opinion on the management of infection caused by azole-resistant Aspergillus fumigatus","volume":"21-22","author":"Verweij","year":"2015","journal-title":"Drug Resist. Updat."},{"issue":"Suppl. 1","key":"10.1016\/j.taap.2017.08.017_bb0165","first-page":"121","article-title":"The comparison of impedance-based method of cell proliferation monitoring with commonly used metabolic-based techniques","volume":"30","author":"Vistejnova","year":"2009","journal-title":"Neuro Endocrinol. Lett."},{"key":"10.1016\/j.taap.2017.08.017_bb0170","series-title":"Bioinformatics","article-title":"Analysis of impedance-based cellular growth assays","author":"Witzel","year":"2015"},{"key":"10.1016\/j.taap.2017.08.017_bb0175","doi-asserted-by":"crossref","first-page":"154","DOI":"10.1021\/tx049721s","article-title":"Dynamic monitoring of cytotoxicity on microelectronic sensors","volume":"18","author":"Xing","year":"2005","journal-title":"Chem. Res. Toxicol."}],"container-title":["Toxicology and Applied Pharmacology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0041008X17303563?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0041008X17303563?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2018,8,28]],"date-time":"2018-08-28T01:52:18Z","timestamp":1535421138000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0041008X17303563"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017,11]]},"references-count":35,"alternative-id":["S0041008X17303563"],"URL":"https:\/\/doi.org\/10.1016\/j.taap.2017.08.017","relation":{},"ISSN":["0041-008X"],"issn-type":[{"value":"0041-008X","type":"print"}],"subject":[],"published":{"date-parts":[[2017,11]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"A cell impedance-based real-time in vitro assay to assess the toxicity of amphotericin B formulations","name":"articletitle","label":"Article Title"},{"value":"Toxicology and Applied Pharmacology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.taap.2017.08.017","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2017 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}